Uwe Mäder

Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients

Frederik A. Verburg, Uwe Mäder, Karina Tanase et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 186 citations · Full text

No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer

Frederik A. Verburg, Marcel P. M. Stokkel, Christian Düren et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 109 citations

Survival Difference, Cancer Management, Thyroid Disease +6

Changing Trends of Incidence and Prognosis of Thyroid Carcinoma in Lower Franconia, Germany, from 1981–1995

Jamshid Farahati, M. Geling, Uwe Mäder et al. · Thyroid · 2004 · 92 citations

Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical¹³¹I Therapy in Both High- and Low-Risk Patients

Frederik A. Verburg, Uwe Mäder, Christoph Reiners et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 89 citations · Full text

Impact of moderate <i>vs</i> stringent TSH suppression on survival in advanced differentiated thyroid carcinoma

Barbara Holzberger, Uwe Mäder, I. Grelle et al. · Clinical Endocrinology · 2011 · 84 citations · Full text